Application 073403
- Type
- ANDA
- Sponsor
- APOTHECON
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | QUESTRAN | CHOLESTYRAMINE | TABLET;ORAL | EQ 1GM RESIN | No | No |
| 002 | QUESTRAN | CHOLESTYRAMINE | TABLET;ORAL | EQ 800MG RESIN | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A073403-001 | QUESTRAN | CHOLESTYRAMINE | EQ 1GM RESIN | TABLET / ORAL | 1994-04-28 | ||
| A073403-002 | QUESTRAN | CHOLESTYRAMINE | EQ 800MG RESIN | TABLET / ORAL | 1999-12-27 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A073403-001 | QUESTRAN | EQ 1GM RESIN | TABLET / ORAL | 1994-04-28 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A073403-002 | QUESTRAN | EQ 800MG RESIN | TABLET / ORAL | 1999-12-27 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A073403-001 | QUESTRAN | EQ 1GM RESIN | TABLET / ORAL | 1994-04-28 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A073403-002 | QUESTRAN | EQ 800MG RESIN | TABLET / ORAL | 1999-12-27 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A073403-001 | QUESTRAN | EQ 1GM RESIN | TABLET / ORAL | 1994-04-28 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A073403-002 | QUESTRAN | EQ 800MG RESIN | TABLET / ORAL | 1999-12-27 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A073403-001 | QUESTRAN | EQ 1GM RESIN | TABLET / ORAL | 1994-04-28 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A073403-002 | QUESTRAN | EQ 800MG RESIN | TABLET / ORAL | 1999-12-27 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A073403-001 | QUESTRAN | EQ 1GM RESIN | TABLET / ORAL | 1994-04-28 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A073403-002 | QUESTRAN | EQ 800MG RESIN | TABLET / ORAL | 1999-12-27 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A073403-001 | QUESTRAN | EQ 1GM RESIN | TABLET / ORAL | 1994-04-28 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A073403-002 | QUESTRAN | EQ 800MG RESIN | TABLET / ORAL | 1999-12-27 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A073403-001 | QUESTRAN | EQ 1GM RESIN | TABLET / ORAL | 1994-04-28 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A073403-002 | QUESTRAN | EQ 800MG RESIN | TABLET / ORAL | 1999-12-27 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A073403-001 | QUESTRAN | EQ 1GM RESIN | TABLET / ORAL | 1994-04-28 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A073403-002 | QUESTRAN | EQ 800MG RESIN | TABLET / ORAL | 1999-12-27 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A073403-001 | QUESTRAN | EQ 1GM RESIN | TABLET / ORAL | 1994-04-28 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A073403-002 | QUESTRAN | EQ 800MG RESIN | TABLET / ORAL | 1999-12-27 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A073403-001 | QUESTRAN | EQ 1GM RESIN | TABLET / ORAL | 1994-04-28 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A073403-002 | QUESTRAN | EQ 800MG RESIN | TABLET / ORAL | 1999-12-27 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A073403-001 | QUESTRAN | EQ 1GM RESIN | TABLET / ORAL | 1994-04-28 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A073403-002 | QUESTRAN | EQ 800MG RESIN | TABLET / ORAL | 1999-12-27 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A073403-001 | QUESTRAN | EQ 1GM RESIN | TABLET / ORAL | 1994-04-28 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A073403-002 | QUESTRAN | EQ 800MG RESIN | TABLET / ORAL | 1999-12-27 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A073403-001 | QUESTRAN | EQ 1GM RESIN | TABLET / ORAL | 1994-04-28 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A073403-002 | QUESTRAN | EQ 800MG RESIN | TABLET / ORAL | 1999-12-27 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A073403-001 | QUESTRAN | EQ 1GM RESIN | TABLET / ORAL | 1994-04-28 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A073403-002 | QUESTRAN | EQ 800MG RESIN | TABLET / ORAL | 1999-12-27 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A073403-001 | QUESTRAN | EQ 1GM RESIN | TABLET / ORAL | 1994-04-28 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A073403-002 | QUESTRAN | EQ 800MG RESIN | TABLET / ORAL | 1999-12-27 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A073403-001 | QUESTRAN | EQ 1GM RESIN | TABLET / ORAL | 1994-04-28 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A073403-002 | QUESTRAN | EQ 800MG RESIN | TABLET / ORAL | 1999-12-27 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A073403-001 | QUESTRAN | EQ 1GM RESIN | TABLET / ORAL | 1994-04-28 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A073403-002 | QUESTRAN | EQ 800MG RESIN | TABLET / ORAL | 1999-12-27 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A073403-001 | QUESTRAN | EQ 1GM RESIN | TABLET / ORAL | 1994-04-28 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A073403-002 | QUESTRAN | EQ 800MG RESIN | TABLET / ORAL | 1999-12-27 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A073403-001 | QUESTRAN | EQ 1GM RESIN | TABLET / ORAL | 1994-04-28 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A073403-002 | QUESTRAN | EQ 800MG RESIN | TABLET / ORAL | 1999-12-27 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A073403-001 | QUESTRAN | EQ 1GM RESIN | TABLET / ORAL | 1994-04-28 | bb7c543d1eb4… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A073403-002 | QUESTRAN | EQ 800MG RESIN | TABLET / ORAL | 1999-12-27 | bb7c543d1eb4… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cholestyramine | CHOLESTYRAMINE | Bryant Ranch Prepack | cc447b99-e654-42dd-8cf1-f9e7952a25cd | 2026-07-16 | Warnings, Adverse reactions | CHOLESTYRAMINE |
| Cholestyramine | CHOLESTYRAMINE | Bryant Ranch Prepack | b26a13e9-42a2-4869-a00a-672bb1ac4742 | 2026-07-13 | Warnings, Adverse reactions | CHOLESTYRAMINE |
| Cholestyramine | CHOLESTYRAMINE | Bryant Ranch Prepack | 2998a314-deb2-4a02-afab-7e8c868888e2 | 2026-07-13 | Warnings, Adverse reactions | CHOLESTYRAMINE |
| Cholestyramine | CHOLESTYRAMINE | Par Health USA, LLC | b0c65058-22c3-4f57-9b61-9bc6fcd6e240 | 2026-06-15 | Warnings, Adverse reactions | CHOLESTYRAMINE |
| CHOLESTYRAMINE | CHOLESTYRAMINE | EPIC PHARMA, LLC | d02eca8c-18d4-4b11-bb16-08748543b04d | 2026-06-15 | Adverse reactions | CHOLESTYRAMINE |
| CHOLESTYRAMINE | CHOLESTYRAMINE | Zydus Pharmaceuticals (USA) Inc. | acc48703-c15b-4275-aa75-749f1c07dcbb | 2026-04-28 | Adverse reactions | CHOLESTYRAMINE |
| CHOLESTYRAMINE | CHOLESTYRAMINE | Zydus Lifesciences Limited | a86715e3-741f-47c6-9682-1413f0f8ff0c | 2026-04-28 | Adverse reactions | CHOLESTYRAMINE |
| QUESTRAN | CHOLESTYRAMINE | Par Health USA, LLC | 362ddd91-a63f-4ec6-841a-75785dd208c8 | 2026-04-17 | Warnings, Adverse reactions | QUESTRAN CHOLESTYRAMINE |
| Cholestyramine | CHOLESTYRAMINE | Micro Labs Limited | 09420793-7357-4194-8172-0b1cddb167fe | 2026-03-05 | Adverse reactions | CHOLESTYRAMINE |
| CHOLESTYRAMINE | CHOLESTYRAMINE | EPIC PHARMA, LLC | d931e372-2477-4554-912e-9d4d7d538ce2 | 2025-12-17 | Adverse reactions | CHOLESTYRAMINE |
| CHOLESTYRAMINE | CHOLESTYRAMINE | EPIC PHARMA, LLC | c65e556a-3b6a-4466-a7ce-5b24103ed8ad | 2025-12-17 | Adverse reactions | CHOLESTYRAMINE |
| CHOLESTYRAMINE | CHOLESTYRAMINE | PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS | d82647da-465b-4e2e-8cf8-72d50f047b3e | 2025-12-11 | Adverse reactions | CHOLESTYRAMINE |
| Cholestyramine | CHOLESTYRAMINE | Macleods Pharmaceuticals Limited | 8cbb1ed2-66cc-485d-a4b1-920f89fb6b3b | 2025-12-09 | Adverse reactions | CHOLESTYRAMINE |
| Prevalite | CHOLESTYRAMINE | Upsher-Smith Laboratories, LLC | dd434ef8-8af3-434c-a0a0-9a0b18459ba0 | 2025-12-02 | Warnings, Adverse reactions | CHOLESTYRAMINE |
| Cholestyramine | CHOLESTYRAMINE | Ajanta Pharma USA Inc. | a0b64dfe-49bc-45d7-9281-9e9d6e296c40 | 2025-10-08 | Adverse reactions | CHOLESTYRAMINE |
| Cholestyramine | CHOLESTYRAMINE | TAGI Pharma, Inc. | 06261db5-1435-4b91-8b54-71bfcfb1368c | 2025-04-17 | Adverse reactions | CHOLESTYRAMINE |
| Cholestyramine Light | CHOLESTYRAMINE | TAGI Pharma, Inc. | eb85a2c8-cdc3-48bb-844d-e220ae3701a0 | 2025-04-17 | Warnings, Adverse reactions | CHOLESTYRAMINE |
| Cholestyramine | CHOLESTYRAMINE | Precision Dose, Inc. | 8c7fc9c8-318c-42de-a736-c439047d8af8 | 2025-03-12 | Adverse reactions | CHOLESTYRAMINE |
| Cholestyramine | CHOLESTYRAMINE | Macleods Pharmaceuticals Limited | c41529f1-16d2-4ca3-91eb-f809571f5ae3 | 2025-01-30 | Warnings, Adverse reactions | CHOLESTYRAMINE |
| Cholestyramine | CHOLESTYRAMINE | Bryant Ranch Prepack | c58d6bd9-0273-4c16-8533-495170413d8c | 2024-08-23 | Warnings, Adverse reactions | CHOLESTYRAMINE |